ArticleTranslational psychiatry2026
The physiological foundation of extinction improvement by tDCS over the ventromedial prefrontal cortex (vmPFC) in healthy humans: an fMRI study.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A growing body of research highlights the fear extinction model as a key framework for understanding the pathology of anxiety disorders and developing therapeutic interventions. Functional imaging studies link successful extinction recall and reduced amygdala reactivity with ventromedial prefrontal cortex (vmPFC) activity, while dysfunctional vmPFC activity is associated with anxiety pathology. Enhancing vmPFC activity through transcranial direct current stimulation (tDCS) has thus emerged as a promising approach to augment cognitive behavioral therapy (CBT) and therapeutic exposure therapies for anxiety disorders. In this study, anodal tDCS was applied over the vmPFC during the extinction learning phase of a 3-day fear acquisition/extinction paradigm (anodal tDCS: 21, sham tDCS: 23 participants). Skin conductance response (SCR) and Blood Oxygenation Level Dependent (BOLD) brain activity were recorded simultaneously. Healthy participants who received real tDCS showed significantly improved extinction recall compared to the sham tDCS group, as indicated by the SCR. Fear acquisition activated core regions of the fear network, including the anterior cingulate cortex, amygdala, orbitofrontal cortex, and insular cortex. During extinction learning, real tDCS activated both fear and safety networks (particularly the posterior cingulate and middle temporal cortex) during early extinction, while the sham tDCS group showed activity only in the fear network. Furthermore, a decoupling of the vmPFC with fear network regions with real tDCS during extinction was observed, indicating strengthened inhibitory control. These findings suggest that anodal tDCS over the vmPFC promotes early activation of the safety network, enhancing extinction learning and consolidation. This suggests its translational potential as an adjunctive intervention for anxiety disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.